Purification of Bovine Viral Diarrhoea Virus E2 Protein
Author Information
Author(s): Cavallaro Antonino, Mahony Donna, Commins Margaret, Mahony Timothy J, Mitter Neena
Primary Institution: Queensland Agricultural Biotechnology Facility, Agri-Science Queensland, Queensland, Australia
Hypothesis
Can we produce soluble and endotoxin-free BVDV E2 protein from inclusion bodies in E. coli?
Conclusion
A novel method was developed to produce soluble E2-T1 protein from inclusion bodies, effectively removing endotoxins and demonstrating its immunogenic potential.
Supporting Evidence
- The E2 protein is a major immunogenic determinant for BVDV.
- The study achieved a 600-fold reduction in endotoxin levels using Triton X-114.
- Mice immunized with E2-T1 developed a strong antibody response.
Takeaway
Scientists figured out how to make a special protein from a virus in bacteria, and it can help make vaccines without being harmful.
Methodology
The study involved expressing a truncated form of BVDV E2 protein in E. coli, purifying it from inclusion bodies, and using Triton X-114 for endotoxin removal.
Limitations
The study primarily focused on small animal models, and further research is needed to evaluate efficacy in larger animals.
Participant Demographics
C57BL/6J mice were used for immunization studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website